Windlas Biotech Limited — Others, 28-07-2025: Shareholders meeting

Windlas Biotech's 24th Annual General Meeting concluded with key approvals. Shareholders adopted the audited financial statements for the fiscal year ended March 31, 2025, and approved a final dividend of Rs. 5.80 per equity share. The meeting also saw the re-appointment of an Executive Director and the appointment of new Statutory Auditors, M/s J C Bhalla & Co., replacing the previous firm. Significantly, shareholders approved the 'Windlas Plan 2025' and the granting of units to eligible employees, including those from subsidiaries, highlighting a focus on broad-based employee incentives.